Artificial Intelligence (AI) In Respiratory Diseases Market Forecast, Trends, Opportunities And Growth Drivers 2025-2034


Grab 20% Off With Code ONLINE20 On Global market Reports – Evaluate Global Trends, Market Risks, and Competitive Intelligence

How Is the Artificial Intelligence (AI) In Respiratory Diseases Market Size Expected to Evolve From 2025 to 2029?
The artificial intelligence (AI) in respiratory diseases market size has grown steadily in recent years. It will grow from $7.66 billion in 2024 to $7.98 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increasing government regulations, growing environmental concerns, increasing aging population, growing patient-centric healthcare approaches, rise in healthcare infrastructure development.

The artificial intelligence (AI) in respiratory diseases market size is expected to see steady growth in the next few years. It will grow to " $9.7 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing prevalence of respiratory diseases, rising need for early detection and diagnosis, growing environmental pollution, rising healthcare expenditure, research and development initiatives. Major trends in the forecast period include technological advancements, drug discovery and development, personalized treatment plans, telemedicine and remote patient monitoring, remote patient monitoring.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp

What Are the Leading Drivers Behind the Growth of the Artificial Intelligence (AI) In Respiratory Diseases Market?
Growing environmental pollution is expected to propel the growth of artificial intelligence (AI) in the respiratory disease market going forward. Environmental pollution refers to the addition of any substance or form of energy to the environment at a rate faster than it can be dispersed or stored in a harmless form. AI in respiratory diseases has the potential to significantly reduce the impact of environmental pollution on respiratory health by offering real-time monitoring, personalized risk assessments, informed decision-making, and innovative solutions for both individuals and communities. For instance, in June 2024, according to the US Energy Information Administration, a US-based government agency, the CO2 emission in 2021 accounted for 35.72 billion metric tons which increased to 38.50 billion metric tons in 2022. Therefore, growing environmental pollution is driving the growth of artificial intelligence (AI) in the respiratory disease market.

What Are the Emerging Segments Driving Growth in the Artificial Intelligence (AI) In Respiratory Diseases Market?
The artificial intelligence (AI) in respiratory diseasesmarket covered in this report is segmented –

1) By Imaging Type: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease; Interstitial Lung Disease; Pulmonary Infection
3) By End Use: Hospital; Diagnostic Centers; Ambulatory Surgical Centers; Other End-Users

Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging; Thoracic Imaging; Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT); Low-Dose CT; Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking; Medication Adherence Monitoring; Quality Of Life Assessments

Which Future-Ready Trends Are Expected to Influence the Artificial Intelligence (AI) In Respiratory Diseases Market?
Major companies operating in artificial intelligence (AI) in the respiratory diseases market are developing innovative products such as N-Tidal devices to monitor patients' tidal breathing. The n-Tidal device measures the volume of air exchanged during normal breathing and provides valuable information about lung function. For instance, in August 2023, TidalSense, a UK-based respiratory technology company, launched N-Tidal, a regulated AI technology for chronic obstructive pulmonary disease (COPD) diagnosis and management. The technology combines N-Tidal's CO2 sensor data with an artificial intelligence platform to measure changes in lung function, aiming to improve the diagnosis and management of this respiratory condition. Clinical studies have demonstrated the technology's high accuracy, and it is expected to reform the diagnostic process for respiratory diseases. The launch is a significant development in the use of AI for respiratory disease assessment, offering a more comfortable and efficient alternative to existing diagnostic tests.

Who Are the Principal Market Leaders in the Artificial Intelligence (AI) In Respiratory Diseases Market?
Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.

Get the detailed artificial intelligence (ai) in respiratory diseases market report today
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

Which Regions Are Expected to Record the Strongest CAGR in the Artificial Intelligence (AI) In Respiratory Diseases Market?
North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more